Sequence-dependent combination therapy with doxorubicin and a survivin-specific small interfering RNA nanodrug demonstrates efficacy in models of adenocarcinoma.
| Image |  |
|---|---|
| Description | scientific article published on 15 October 2013 |
| Author/s |
author: Anna M. Moore Natasha Barteneva |
| Publication date | October 15, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |